-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. ROLE SUMMARY As a member of our NGS and Data Science team, you will
-
to support decision making in the drug development process. The General Toxicology R6 Study Director is responsible for the design, conduct, interpretation, and reporting of exploratory, mechanistic and GLP in
-
ROLE SUMMARY Device and Combination Product Development (DCP) is a drug/device combination product design and development organization focused on improving patients' lives through customer-focused
-
Why Patients Need You Whether you are involved in the design and development of manufacturing processes for products or supporting maintenance and reliability, engineering is vital to making sure
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve Drug Safety Research & Development (DSRD) is
-
data infrastructure Design, develop, optimize, and maintain data architecture and pipelines (e.g., feeding medical data sources into data lake for ongoing projects) Partner with product manager and data
-
data infrastructure Design, develop, optimize, and maintain data architecture and pipelines (e.g., feeding medical data sources into data lake for ongoing projects) Partner with product manager and data
-
contemporary design tools to drive effective target design and prioritization within a portfolio of projects Contribute to ADC payload strategy and utilize experience in synthetic chemistry and methodology
-
-leading team whose mission is to identify key risks associated with unwanted clinical immunogenicity and influence drug design to mitigate those risks. We are currently seeking an experienced immunogenicity
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve You will participate in pre-clinical oncology